{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:04:01Z","timestamp":1787508241872,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11845-018-1777-2","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T03:33:52Z","timestamp":1520566432000},"page":"1057-1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Neurological autoantibodies in drug-resistant epilepsy of unknown cause"],"prefix":"10.1007","volume":"187","author":[{"given":"Mehmet","family":"Tecellioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozden","family":"Kamisli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suat","family":"Kamisli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Ebru","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemal","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"1777_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fneur.2017.00459","volume":"8","author":"F Murgia","year":"2017","unstructured":"Murgia F, Muroni A, Puligheddu M, Polizzi L, Barberini L, Orofino G, Solla P, Poddighe S, del Carratore F, Griffin JL, Atzori L, Marrosu F (2017) Metabolomics as a tool for the characterization of drug-resistant epilepsy. Front Neurol 8:459. \n                    https:\/\/doi.org\/10.3389\/fneur.2017.00459","journal-title":"Front Neurol"},{"issue":"9","key":"1777_CR2","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Mosh\u00e9 SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(9):1922\u20131077. \n                    https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02397.x","journal-title":"Epilepsia"},{"key":"1777_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3949\/ccjm.77a.09061","volume":"77","author":"S Pati","year":"2010","unstructured":"Pati S, Alexopoulos AV (2010) Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies. Cleve Clin J Med 77:457\u2013467. \n                    https:\/\/doi.org\/10.3949\/ccjm.77a.09061","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"1777_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1528-1167.2010.02969.x","volume":"52","author":"EC Wirrell","year":"2011","unstructured":"Wirrell EC, Grossardt BR, Elson LS et al (2011) A population-based study of long-term outcomes of cryptogenic focal epilepsy in childhood: cryptogenic epilepsy is not probably symptomatic epilepsy. Epilepsia 52(4):738\u2013745. \n                    https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02969.x","journal-title":"Epilepsia"},{"key":"1777_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/WCO.0b013e32833735fe","volume":"23","author":"A Vincent","year":"2010","unstructured":"Vincent A, Irani SR, Lang B (2010) The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 23:144\u2013150. \n                    https:\/\/doi.org\/10.1097\/WCO.0b013e32833735fe","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"1777_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","volume":"69","author":"AM Quek","year":"2012","unstructured":"Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein C, Watson RE Jr, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA, Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ (2012) Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 69(5):582\u2013593. \n                    https:\/\/doi.org\/10.1001\/archneurol.2011.2985","journal-title":"Arch Neurol"},{"issue":"6","key":"1777_CR7","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/epi.12127","volume":"54","author":"T Brenner","year":"2013","unstructured":"Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ, Vincent A, Lang B (2013) Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 54(6):1028\u20131035. \n                    https:\/\/doi.org\/10.1111\/epi.12127","journal-title":"Epilepsia"},{"issue":"1","key":"1777_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1468-1331.2008.02373.x","volume":"16","author":"S Liimatainen","year":"2009","unstructured":"Liimatainen S, Peltola M, Fallah M, Kharazmi E, Haapala AM, Peltola J (2009) The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures. Eur J Neurol 16(1):134\u2013141. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02373.x","journal-title":"Eur J Neurol"},{"issue":"9","key":"1777_CR9","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0002-9343(00)00617-3","volume":"109","author":"JT Peltola","year":"2000","unstructured":"Peltola JT, Haapala AM, Isoj\u00e4rvi JI, Auvinen A, Palmio J, Latvala K, Kulmala P, Laine S, Vaarala O, Ker\u00e4nen T (2000) Antiphospholipid and antinuclear antibodies in epileptic syndromes and new-onset seizure disorders. Am J Med 109(9):712\u2013717. \n                    https:\/\/doi.org\/10.1016\/S0002-9343(00)00617-3","journal-title":"Am J Med"},{"key":"1777_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.eplepsyres.2003.12.004","volume":"58","author":"J Ranua","year":"2004","unstructured":"Ranua J, Luoma K, Peltola J, Haapala AM, Raitanen J, Auvinen A, Isoj\u00e4rvi J (2004) Anticardiolipin and antinuclear antibodies in epilepsy\u2014a population-based cross-sectional study. Epilepsy Res 58:13\u201318. \n                    https:\/\/doi.org\/10.1016\/j.eplepsyres.2003.12.004","journal-title":"Epilepsy Res"},{"issue":"4","key":"1777_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","volume":"74","author":"D Dubey","year":"2017","unstructured":"Dubey D, Alqallaf A, Hays R, Freeman M, Chen K, Ding K, Agostini M, Vernino S (2017) Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol 74(4):397\u2013402. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2016.5429","journal-title":"JAMA Neurol"},{"key":"1777_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yebeh.2016.04.046","volume":"61","author":"A Serafini","year":"2016","unstructured":"Serafini A, Lukas RV, VanHaerents S, Warnke P, Tao JX, Rose S, Wu S (2016) Paraneoplastic epilepsy. Epilepsy Behav 61:51\u201358. \n                    https:\/\/doi.org\/10.1016\/j.yebeh.2016.04.046","journal-title":"Epilepsy Behav"},{"issue":"13","key":"1777_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1177\/0961203316651747","volume":"25","author":"MHA Noureldine","year":"2016","unstructured":"Noureldine MHA, Harifi G, Berjawi A, Haydar AA, Nader M, Elnawar R, Sweid A, al Saleh J, Khamashta MA, Uthman I (2016) Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies. Lupus 25(13):1397\u20131411. \n                    https:\/\/doi.org\/10.1177\/0961203316651747","journal-title":"Lupus"},{"issue":"4","key":"1777_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Mosh\u00e9 SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM (2017) ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):512\u2013521. \n                    https:\/\/doi.org\/10.1111\/epi.13709","journal-title":"Epilepsia"},{"key":"1777_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.eplepsyres.2017.06.008","volume":"135","author":"G Gozubatik-Celik","year":"2017","unstructured":"Gozubatik-Celik G, Ozkara C, Ulusoy C, Gunduz A, Delil S, Yeni N, Tuzun E (2017) Anti-neuronal autoantibodies in both drug responsive and resistant focal seizures with unknown cause. Epilepsy Res 135:131\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.06.008","journal-title":"Epilepsy Res"},{"issue":"11","key":"1777_CR16","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","volume":"65","author":"K McKnight","year":"2005","unstructured":"McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, Shoenfeld Y, Vincent A, Palace J, Lang B (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65(11):1730\u20131736. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000187129.66353.13","journal-title":"Neurology"},{"issue":"6","key":"1777_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp.69.6.711","volume":"69","author":"J Palace","year":"2000","unstructured":"Palace J, Lang B (2000) Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 69(6):711\u2013714. \n                    https:\/\/doi.org\/10.1136\/jnnp.69.6.711","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1777_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00281-009-0176-1","volume":"31","author":"J Bauer","year":"2009","unstructured":"Bauer J, Bien C (2009) Encephalitis and epilepsy. Semin Immunopathol 31(4):537\u2013544. \n                    https:\/\/doi.org\/10.1007\/s00281-009-0176-1","journal-title":"Semin Immunopathol"},{"key":"1777_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00405-005-0942-1","volume":"263","author":"LW Baijens","year":"2006","unstructured":"Baijens LW, Manni JJ (2006) Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a review of the literature. Eur Arch Otorhinolaryngol 263:32\u201336. \n                    https:\/\/doi.org\/10.1007\/s00405-005-0942-1","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"1777_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","volume":"71","author":"MS Ong","year":"2014","unstructured":"Ong MS, Kohane IS, Cai T, Gorman MP, Mandl KD (2014) Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol 71(5):569\u2013574. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2014.188","journal-title":"JAMA Neurol"},{"issue":"26","key":"1777_CR21","doi-asserted-by":"publisher","first-page":"e1059","DOI":"10.1097\/MD.0000000000001059","volume":"94","author":"MH Tsai","year":"2015","unstructured":"Tsai MH, Fu TY, Chen NC, Shih FY, Lu YT, Cheng MY, Chuang HY, Chuang YC (2015) Antithyroid antibodies are implicated in epileptogenesis of adult patients with epilepsy. Medicine (Baltimore) 94(26):e1059. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000001059","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1777_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/epi.12528","volume":"55","author":"E Ekizoglu","year":"2014","unstructured":"Ekizoglu E, Tuzun E, Woodhall M, Lang B, Jacobson L, Icoz S, Bebek N, Gurses C, Gokyigit A, Waters P, Vincent A, Baykan B (2014) Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epilepsia 55(3):414\u2013422. \n                    https:\/\/doi.org\/10.1111\/epi.12528","journal-title":"Epilepsia"},{"issue":"2","key":"1777_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/WCO.0b013e3283446f05","volume":"24","author":"SR Irani","year":"2011","unstructured":"Irani SR, Bien CG, Lang B (2011) Autoimmune epilepsies. Curr Opin Neurol 24(2):146\u2013153. \n                    https:\/\/doi.org\/10.1097\/WCO.0b013e3283446f05","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"1777_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/brain\/awh077","volume":"127","author":"A Vincent","year":"2004","unstructured":"Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127(3):701\u2013712. \n                    https:\/\/doi.org\/10.1093\/brain\/awh077","journal-title":"Brain"},{"key":"1777_CR25","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","volume":"62","author":"MJ Thieben","year":"2004","unstructured":"Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S (2004) Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62:1177\u20131182. \n                    https:\/\/doi.org\/10.1212\/01.WNL.0000122648.19196.02","journal-title":"Neurology"},{"issue":"1","key":"1777_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/WNL.55.1.46","volume":"55","author":"J Peltola","year":"2000","unstructured":"Peltola J, Kulmala P, Isoj\u00e4rvi J et al (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurol 55(1):46\u201350. \n                    https:\/\/doi.org\/10.1212\/WNL.55.1.46","journal-title":"Neurol"},{"issue":"2\u20133","key":"1777_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0920-1211(00)00180-7","volume":"42","author":"P Kwan","year":"2000","unstructured":"Kwan P, Sills GJ, Kelly K, Butler E, Brodie MJ (2000) Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 42(2\u20133):191\u2013195. \n                    https:\/\/doi.org\/10.1016\/S0920-1211(00)00180-7","journal-title":"Epilepsy Res"},{"issue":"1\u20132","key":"1777_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2004.01.008","volume":"220","author":"M Vianello","year":"2004","unstructured":"Vianello M, Vitaliani R, Pezzani R, Nicolao P, Betterle C, Keir G, Thompson EJ, Tavolato B, Scaravilli F, Giometto B (2004) The spectrum of antineuronal autoantibodies in a series of neurological patients. J Neurol Sci 220(1\u20132):29\u201336. \n                    https:\/\/doi.org\/10.1016\/j.jns.2004.01.008","journal-title":"J Neurol Sci"},{"issue":"3","key":"1777_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/1550059415595907","volume":"47","author":"L Baysal-Kirac","year":"2016","unstructured":"Baysal-Kirac L, Tuzun E, Altindag E, Ekizoglu E, Kinay D, Bilgic B, Tekturk P, Baykan B (2016) Are there any specific EEG findings in autoimmune epilepsies? Clin EEG Neurosci 47(3):224\u2013234. \n                    https:\/\/doi.org\/10.1177\/1550059415595907","journal-title":"Clin EEG Neurosci"},{"issue":"3","key":"1777_CR30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.eplepsyres.2013.12.015","volume":"108","author":"S Liimatainen","year":"2014","unstructured":"Liimatainen S, Peltola J, Hietaharju A, Sabater L, Lang B (2014) Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy. Epilepsy Res 108(3):592\u2013596. \n                    https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.12.015","journal-title":"Epilepsy Res"},{"key":"1777_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clineuro.2014.03.017","volume":"121","author":"J Miro","year":"2014","unstructured":"Miro J, Fortuny R, Juncadella M et al (2014) Antithyroid antibodies as a potential marker of autoimmune-mediated late onset temporal lobe epilepsy. Clin Neurol Neurosurg 121:46\u201350. \n                    https:\/\/doi.org\/10.1016\/j.clineuro.2014.03.017","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"1777_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/08916938809001927","volume":"1","author":"Y Tomer","year":"1988","unstructured":"Tomer Y, Shoenfeld Y (1988) Ageing and autoantibodies. Autoimmunity 1(2):141\u2013149","journal-title":"Autoimmunity"},{"issue":"3","key":"1777_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2165\/00002018-199308030-00005","volume":"8","author":"F Ponti De","year":"1993","unstructured":"De Ponti F, Lecchini S, Cosentino M et al (1993) Immunological adverse effects of anticonvulsants. What is their clinical relevance? Drug Saf 8(3):235\u2013250","journal-title":"Drug Saf"},{"key":"1777_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1528-1157.2002.00701.x","volume":"43","author":"R Cimaz","year":"2002","unstructured":"Cimaz R, Romeo A, Scarano A, Avin T, Viri M, Veggiotti P, Gatti A, Lodi M, Catelli L, Panzeri P, Cecchini G, Meroni PL (2002) Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia 43:52\u201359. \n                    https:\/\/doi.org\/10.1046\/j.1528-1157.2002.00701.x","journal-title":"Epilepsia"},{"key":"1777_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0002-9343(97)90046-2","volume":"103","author":"D Verrot","year":"1997","unstructured":"Verrot D, San-Marco M, Dravet C, Genton P, Disdier P, Bolla G, Harle JR, Reynaud L, Weiller PJ (1997) Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am J Med 103:33\u201337. \n                    https:\/\/doi.org\/10.1016\/S0002-9343(97)90046-2","journal-title":"Am J Med"},{"issue":"4","key":"1777_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1191\/0961203306lu2272rr","volume":"15","author":"R Cimaz","year":"2006","unstructured":"Cimaz R, Meroni PL, Shoenfeld Y (2006) Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). Lupus 15(4):191\u2013197. \n                    https:\/\/doi.org\/10.1191\/0961203306lu2272rr","journal-title":"Lupus"},{"issue":"2","key":"1777_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.semarthrit.2009.05.001","volume":"40","author":"Y Arnson","year":"2010","unstructured":"Arnson Y, Shoenfeld Y, Alon E, Amital H (2010) The antiphospholipid syndrome as a neurological disease. Semin Arthritis Rheum 40(2):97\u2013108. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2009.05.001","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1777_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","volume":"71","author":"J Dalmau","year":"1992","unstructured":"Dalmau J, Graus F, Rosenblum MK et al (1992) Anti-Hu-associated paraneoplastic encephalomyelitis\/sensory neuronopathy: a clinical study of 71 patients. Medicine (Baltimore) 71(2):59\u201372","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1777_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/epi.12184","volume":"54","author":"CG Bien","year":"2013","unstructured":"Bien CG (2013) Value of autoantibodies for prediction of treatment response in patients with autoimmune epilepsy: review of the literature and suggestions for clinical management. Epilepsia 54(2):48\u201355. \n                    https:\/\/doi.org\/10.1111\/epi.12184","journal-title":"Epilepsia"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-018-1777-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-018-1777-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-018-1777-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T19:36:09Z","timestamp":1552073769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-018-1777-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1777"],"URL":"https:\/\/doi.org\/10.1007\/s11845-018-1777-2","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This article does not include any studies with animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures in studies involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}}]}}